168 related articles for article (PubMed ID: 10528783)
21. Susceptibility of Staphylococcus aureus to fusidic acid: Canadian data.
Rennie RP
J Cutan Med Surg; 2006; 10(6):277-80. PubMed ID: 17241597
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of fusidic acid in therapy of experimental Staphylococcus aureus meningitis.
Østergaard C; Yieng-Kow RV; Knudsen JD; Frimodt-Møller N; Espersen F
J Antimicrob Chemother; 2003 May; 51(5):1301-5. PubMed ID: 12697637
[TBL] [Abstract][Full Text] [Related]
23. Fusidic acid for the treatment of bone and joint infections caused by meticillin-resistant Staphylococcus aureus.
Wang JL; Tang HJ; Hsieh PH; Chiu FY; Chen YH; Chang MC; Huang CT; Liu CP; Lau YJ; Hwang KP; Ko WC; Wang CT; Liu CY; Liu CL; Hsueh PR
Int J Antimicrob Agents; 2012 Aug; 40(2):103-7. PubMed ID: 22612900
[TBL] [Abstract][Full Text] [Related]
24. Fusidic acid in other infections.
Golledge C
Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S11-5. PubMed ID: 10528782
[TBL] [Abstract][Full Text] [Related]
25. Fusidic acid in bone and joint infections.
Atkins B; Gottlieb T
Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S79-93. PubMed ID: 10528790
[TBL] [Abstract][Full Text] [Related]
26. [Bacteriological studies in the therapy of treatment-resistant staphylococcal infections with fusidic acid].
Roser H
Med Welt; 1967 May; 21():1325-9. PubMed ID: 5612546
[No Abstract] [Full Text] [Related]
27. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin.
Mohan SS; McDermott BP; Cunha BA
Heart Lung; 2005; 34(1):69-71. PubMed ID: 15647736
[TBL] [Abstract][Full Text] [Related]
28. In vitro activity of two old antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus.
Yu XH; Song XJ; Cai Y; Liang BB; Lin DF; Wang R
J Antibiot (Tokyo); 2010 Nov; 63(11):657-9. PubMed ID: 20877368
[TBL] [Abstract][Full Text] [Related]
29. Telavancin for refractory methicillin-resistant Staphylococcus aureus bacteremia and infective endocarditis.
Ruggero MA; Peaper DR; Topal JE
Infect Dis (Lond); 2015 Jun; 47(6):379-84. PubMed ID: 25746601
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of Staphylococcus aureus endocarditis and septicemia].
Frimodt-Møller N; Espersen F; Thomsen VF
Ugeskr Laeger; 1984 Nov; 146(45):3431-4. PubMed ID: 6515969
[No Abstract] [Full Text] [Related]
31. Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan.
Huang YT; Hsiao CH; Liao CH; Lee CW; Hsueh PR
J Clin Microbiol; 2008 Mar; 46(3):1132-6. PubMed ID: 18199793
[TBL] [Abstract][Full Text] [Related]
32. Fusidic acid and heparin lock solution for the prevention of catheter-related bloodstream infections in critically ill neonates: a retrospective study and a prospective, randomized trial.
Filippi L; Pezzati M; Di Amario S; Poggi C; Pecile P
Pediatr Crit Care Med; 2007 Nov; 8(6):556-62. PubMed ID: 17914310
[TBL] [Abstract][Full Text] [Related]
33. Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with telavancin.
Nace H; Lorber B
J Antimicrob Chemother; 2010 Jun; 65(6):1315-6. PubMed ID: 20375035
[No Abstract] [Full Text] [Related]
34. Clinical significance of tolerant strains of Staphylococcus aureus in patients with endocarditis.
Rajashekaraiah KR; Rice T; Rao VS; Marsh D; Ramakrishna B; Kallick CA
Ann Intern Med; 1980 Dec; 93(6):796-801. PubMed ID: 6905714
[TBL] [Abstract][Full Text] [Related]
35. Methicillin-resistant Staphylococcus aureus infections.
Taylor AR
Prim Care; 2013 Sep; 40(3):637-54. PubMed ID: 23958361
[TBL] [Abstract][Full Text] [Related]
36. [Consensus document for the treatment of bacteremia and endocarditis caused by methicillin-resistent Staphylococcus aureus. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica].
Gudiol F; Aguado JM; Pascual A; Pujol M; Almirante B; Miró JM; Cercenado E; Domínguez Mde L; Soriano A; Rodríguez-Baño J; Vallés J; Palomar M; Tornos P; Bouza E;
Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):105-15. PubMed ID: 19254641
[TBL] [Abstract][Full Text] [Related]
37. [Severe methicillin-resistant Staphylococcus aureus infections. Emergence of resistance to fusidic acid or fosfomycin during treatment with continuous infusion of vancomycin].
Georges B; Brown L; Mazerolles M; Decun JF; Cougot P; Archambaud M; Suc C; Andrieu P; Virenque C
Presse Med; 1997 Apr; 26(11):502-6. PubMed ID: 9137379
[TBL] [Abstract][Full Text] [Related]
38. Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy.
Ho TT; Cadena J; Childs LM; Gonzalez-Velez M; Lewis JS
J Antimicrob Chemother; 2012 May; 67(5):1267-70. PubMed ID: 22311935
[TBL] [Abstract][Full Text] [Related]
39. Staphylococci and combination therapy.
Andriole VT
Arch Intern Med; 1979 Oct; 139(10):1090-1. PubMed ID: 485736
[No Abstract] [Full Text] [Related]
40. Daptomycin and rifampin for the treatment of methicillin-resistant Staphylococcus aureus septic pulmonary emboli in the absence of endocarditis.
Gomez EO; Jafary A; Dever LL
Microb Drug Resist; 2010 Sep; 16(3):241-4. PubMed ID: 20617926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
